{
  "id": 5802,
  "url": "https://nnemf.org/research/5802-impact-of-ketamine-administration-on-chronic-unpredictable-stress",
  "title": "Impact of ketamine administration on chronic unpredictable stress-induced rat model of depression during extremely low-frequency electromagnetic field exposure: Behavioral, histological and molecular study.",
  "authors": [
    "Moein Salari",
    "Seyed Hassan Eftekhar-Vaghefi",
    "Majid Asadi-Shekaari",
    "Khadijeh Esmaeilpour",
    "Somayeh Solhjou",
    "Maryam Amiri",
    "Meysam Ahmadi-Zeidabadi"
  ],
  "journal": "Brain and behavior",
  "year": "2023",
  "doi": "10.1002/brb3.2986",
  "pmid": "37032465",
  "abstract": "OBJECTIVES: In the study, we examined the effects of ketamine and extremely low-frequency electromagnetic fields (ELF-EMF) on depression-like behavior, learning and memory, expression of GFAP, caspase-3, p53, BDNF, and NMDA receptor in animals subjected to chronic unpredictable stress (CUS). METHODS: After applying 21 days of chronic unpredictable stress, male rats received intraperitoneal (IP) of ketamine (5 mg/kg) and then were exposed to ELF-EMF (10-Hz, 10-mT exposure conditions) for 3 days (3 h per day) and behavioral assessments were performed 24 h after the treatments. Instantly after the last behavioral test, the brain was extracted for Nissl staining, immunohistochemistry, and real-time PCR analyses. Immunohistochemistry (IHC) was conducted to assess the effect of ketamine and ELF-EMF on the expression of astrocyte marker (glial fibrillary acidic protein, GFAP) in the CA1 area of the hippocampus and medial prefrontal cortex (mPFC). Also, real-time PCR analyses were used to investigate the impacts of the combination of ketamine and ELF-EMF on the expression of caspase3, p53, BDNF, and NMDA receptors in the hippocampus in rats submitted to the CUS procedure. Results were considered statistically significant when p < .05. RESULTS: Our results revealed that the combination of ketamine and ELF-EMF increased depression-like behavior, increased degenerated neurons and decreased the number of GFAP (+) cells in the CA1 area and mPFC, incremented the expression of caspase-3, and reduced the expression of BDNF in the hippocampus but showed no effect on the expression of p53 and NMDA-R. CONCLUSIONS: These results reveal that combining ketamine and ELF-EMF has adverse effects on animals under chronic unpredictable stress (CUS).",
  "effect": "harm",
  "evidence": "low",
  "extraction": {
    "studyType": "animal",
    "studyTypeLabel": "Animal study",
    "effectDirection": "harm",
    "evidenceLabel": "Low",
    "population": "Male rats subjected to chronic unpredictable stress (CUS)",
    "sampleSize": "—",
    "exposure": "ELF · 3 days (3 h/day) after 21 days CUS; exposure conditions 10 Hz, 10 mT",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "In CUS-exposed male rats, the combination of ketamine (5 mg/kg IP) and ELF-EMF exposure (10 Hz, 10 mT; 3 h/day for 3 days) increased depression-like behavior, increased degenerated neurons, decreased GFAP(+) cells in CA1 and mPFC, increased caspase-3 expression, and decreased BDNF expression in the hippocampus. No effects were observed on p53 or NMDA receptor expression.",
    "outcomes": [
      "Depression-like behavior",
      "Learning and memory (behavioral assessments)",
      "Neuronal degeneration (Nissl staining)",
      "GFAP(+) astrocyte marker expression in CA1 hippocampus and medial prefrontal cortex (IHC)",
      "Hippocampal gene expression of caspase-3",
      "p53",
      "BDNF",
      "NMDA receptor (real-time PCR)"
    ],
    "limitations": [
      "Sample size not reported in abstract",
      "Study evaluates combined ketamine + ELF-EMF effects",
      "effects of ELF-EMF alone are not described in the abstract",
      "Details of learning/memory results are not provided in the abstract",
      "Exposure source/setup not specified in abstract"
    ],
    "keywords": [
      "extremely low-frequency electromagnetic field",
      "ELF-EMF",
      "10 Hz",
      "10 mT",
      "chronic unpredictable stress",
      "CUS",
      "rat model",
      "depression-like behavior",
      "ketamine",
      "GFAP",
      "caspase-3",
      "p53",
      "BDNF",
      "NMDA receptor",
      "hippocampus",
      "medial prefrontal cortex"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"animal\",\n  \"exposure\": {\n    \"band\": \"ELF\",\n    \"source\": null,\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": \"3 days (3 h/day) after 21 days CUS; exposure conditions 10 Hz, 10 mT\"\n  },\n  \"population\": \"Male rats subjected to chronic unpredictable stress (CUS)\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Depression-like behavior\",\n    \"Learning and memory (behavioral assessments)\",\n    \"Neuronal degeneration (Nissl staining)\",\n    \"GFAP(+) astrocyte marker expression in CA1 hippocampus and medial prefrontal cortex (IHC)\",\n    \"Hippocampal gene expression of caspase-3, p53, BDNF, NMDA receptor (real-time PCR)\"\n  ],\n  \"main_findings\": \"In CUS-exposed male rats, the combination of ketamine (5 mg/kg IP) and ELF-EMF exposure (10 Hz, 10 mT; 3 h/day for 3 days) increased depression-like behavior, increased degenerated neurons, decreased GFAP(+) cells in CA1 and mPFC, increased caspase-3 expression, and decreased BDNF expression in the hippocampus. No effects were observed on p53 or NMDA receptor expression.\",\n  \"effect_direction\": \"harm\",\n  \"limitations\": [\n    \"Sample size not reported in abstract\",\n    \"Study evaluates combined ketamine + ELF-EMF effects; effects of ELF-EMF alone are not described in the abstract\",\n    \"Details of learning/memory results are not provided in the abstract\",\n    \"Exposure source/setup not specified in abstract\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"extremely low-frequency electromagnetic field\",\n    \"ELF-EMF\",\n    \"10 Hz\",\n    \"10 mT\",\n    \"chronic unpredictable stress\",\n    \"CUS\",\n    \"rat model\",\n    \"depression-like behavior\",\n    \"ketamine\",\n    \"GFAP\",\n    \"caspase-3\",\n    \"p53\",\n    \"BDNF\",\n    \"NMDA receptor\",\n    \"hippocampus\",\n    \"medial prefrontal cortex\"\n  ],\n  \"suggested_hubs\": [\n    {\n      \"slug\": \"elr-elf-emf\",\n      \"weight\": 0.86,\n      \"reason\": \"Animal study with extremely low-frequency EMF exposure (10 Hz, 10 mT) and neurobehavioral/molecular outcomes.\"\n    }\n  ]\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/37032465/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=5802",
  "updated": "2026-02-14 08:52:50"
}